Celularity Inc (CELU) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Celularity Inc   (NASDAQ: CELU)
 

Celularity Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Celularity Inc inventory turnover ratio, the Celularity Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 13.93 in the second quarter 2026, a new company high. Average inventory processing period, for the Celularity Inc in Jun 30 2026 quarter, has decreased to 26 days, compare to 41 days, in the Mar 31 2026 quarter.

Within Healthcare sector 27 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 803, from total ranking in the first quarter 2026 at 960.

CELU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Celularity Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELU Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -83.72 % -92.3 % -89.44 % -35.33 % 51.29 %
Y / Y Cost of Sales Growth -55.23 % -59.14 % 0.42 % 0.54 % 146.91 %
Inventory Turnover Ratio (TTM) 13.93 8.96 5.84 4.32 4.01
CELU's Total Ranking # 803 # 960 # 1008 # 1088 # 1271
Average inventory processing period 26 41 62 85 91
Seq. Inventory Growth 50.52 % -16.46 % -77.72 % -41.88 % -28.84 %
Seq. Cost of Sales Growth 61.64 % -80.31 % 88.88 % -25.52 % 47.5 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 28
Overall Market # 803

Inventory Turnover Ratio Statistics
High Average Low
13.93 3.95 0.19
(Jun 30 2026)   (Dec 31 2022)



CELU Company Profile >> Back to CELU Efficiency Comparisons >> Compare CELU Inventory Turnover Ratio to its Competitors

Financial Statements
Celularity Inc 's Inventories $ 1 Millions Visit CELU's Balance sheet
Celularity Inc 's Cost of Revenues TTM $ 15 Millions Visit CELU's Income Statement
What are CELU's Sales? Visit CELU's Sales by Segment

Other Inventory Turnover Ratios
Celularity Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CELU's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CELU's Competitors
Inventory Turnover Ratio for CELU's Suppliers
Inventory Turnover Ratio for CELU's Customers

You may also want to know
CELU's Sales Growth Rates CELU's Pe Price to earnings ratio CELU's Receivables Turnover Ratio CELU's Stock Quote
CELU's Net Income Growth Rates CELU's Ps Price to Sales ratio CELU's Sales per Employee CELU's Asset Turnover Ratio
CELU's Net Margin CELU's Pb Price to Book ratio CELU's Financial Strength Ratios CELU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Harmony Biosciences Holdings inc   39.56 $ 236.198  Millions$ 6  Millions
Qhslab Inc   39.48 $ 0.975  Millions$ 0  Millions
Quest Diagnostics Inc  37.13 $ 7,732.000  Millions$ 208  Millions
Vaso Corporation  33.32 $ 28.238  Millions$ 1  Millions
Prophase Labs Inc   26.86 $ 3.196  Millions$ 0  Millions
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Viemed Healthcare Inc   24.71 $ 128.283  Millions$ 5  Millions
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Adapthealth Corp   19.31 $ 2,552.376  Millions$ 132  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Aspira Women s Health inc   19.13 $ 5.073  Millions$ 0  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Celularity Inc   13.93 $ 15.077  Millions$ 1  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Option Care Health Inc   10.83 $ 4,607.869  Millions$ 426  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions

Date modified: 2026-10-21T15:15:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.